BOLD
Boundless Bio, Inc.NASDAQHealthcare$1.08+9.26%ClosedMarket Cap: $24.2M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.27
P/S
0.00
EV/EBITDA
-0.97
DCF Value
$-1.46
FCF Yield
-178.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-49.7%
ROA
-37.1%
ROIC
-43.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-14.0M | $-12.9M | $-0.58 | — |
| FY 2025 | $0.00 | -Infinity% | $-63.6M | $-58.2M | $-2.60 | — |
| Q3 2025 | $0.00 | -Infinity% | $-15.1M | $-13.9M | $-0.62 | — |
| Q2 2025 | $0.00 | -Infinity% | $-17.1M | $-15.7M | $-0.70 | — |
| Q1 2025 | $0.00 | NaN% | $-17.3M | $-15.8M | $-0.71 | — |
| Q4 2024 | $0.00 | NaN% | $-18.3M | $-16.4M | $-0.84 | — |
| FY 2024 | $0.00 | -Infinity% | $-73.3M | $-65.4M | $-3.85 | — |
| Q3 2024 | $0.00 | NaN% | $-18.7M | $-16.5M | $-0.74 | — |
| Q2 2024 | $0.00 | -Infinity% | $-19.4M | $-17.0M | $-0.77 | — |
| Q1 2024 | $0.00 | NaN% | $-16.9M | $-15.4M | $-0.69 | — |
| Q4 2023 | $0.00 | NaN% | $-13.8M | $-12.1M | $-0.55 | — |
| FY 2023 | $0.00 | NaN% | $-54.8M | $-49.4M | $-2.22 | — |